Mathieu Robain

Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort

Élisa Gobbini, Monia Ezzalfani, Véronique Dièras et al. · European Journal of Cancer · 2018 · 281 citations

Medicine, Biostatistics, Oncology +17

Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort

Amélie Darlix, G. Louvel, Julien Fraisse et al. · British Journal of Cancer · 2019 · 221 citations · Full text

Medicine, Oncology, Breast Oncology +15

Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008–2016

Élise Deluche, Alison Antoine, Thomas Bachelot et al. · European Journal of Cancer · 2020 · 192 citations

Medicine, Gynecology, Oncology +17

Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort

Thomas Grinda, Alison Antoine, William Jacot et al. · ESMO Open · 2021 · 134 citations · Full text

Medicine, Oncology, Breast Oncology +12

Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study

Suzette Delaloge, David Pérol, Coralie Courtinard et al. · Annals of Oncology · 2016 · 73 citations

Medicine, Oncology, Pharmacology +16